Testing effectiveness (Phase 2)Study completedNCT01693068
What this trial is testing
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Who this might be right for
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma
EMD Serono 194